My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
AstraZeneca Pharma drops after receiving distribution termination notice for product
Aug 25,2016

The announcement was made after market hours yesterday, 24 August 2016. Shares of Pfizer, Indian arm of Pfizer Inc. rose 1.07% to Rs 1,960.

Meanwhile, the S&P BSE Sensex was up 50.32 points or 0.18% at 28,110.26.

Higher than usual volumes were witnessed on the counter of AstraZeneca Pharma India. On BSE, so far 9,144 shares were traded in the counter as against average daily volume of 2,152 shares in the past one quarter. The stock hit a high of Rs 1,120 and a low of Rs 1,050 so far during the day. The stock had hit a 52-week high of Rs 1,348 on 12 January 2016. The stock had hit a 52-week low of Rs 995.40 on 9 August 2016. The stock had outperformed the market over the past one month till 24 August 2016, rising 9.21% compared with 0.92% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, gaining 4.29% as against Sensexs 10.88% rise.

The mid-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

AstraZeneca Pharma India announced that AstraZeneca UK terminated distribution arrangements with the company for Meronem (meropenem) in India. The termination was a result of global agreement by a parent firm, AstraZeneca PLC to sell the development and commercialisation rights to Pfizer Inc, of its late stage small molecule antibiotics business. Meronem is a carbapenem anti-bacterial used for the treatment of serious infections in hospitalised patients. Meronem is currently AstraZeneca Pharma Indias principal product, which generated 18% of the total turnover of the company in the year ended 31 March 2016 (FY 2016). The current distribution arrangements for Meronem in India will terminate in six months from 24 August 2016.

AstraZeneca PLC, parent company of AstraZeneca Pharma India announced yesterday, 24 August 2016 that it has entered into an agreement with Pfizer Inc. to sell the commercialisation and development rights to its late-stage small molecule antibiotics business in most markets globally outside the US. The agreement reinforces AstraZenecas focus on developing transformational medicines in its three main therapy areas cardiovascular & metabolic diseases, respiratory and oncology, while realising value from the strong portfolio of established and late-stage small molecule antibiotics through Pfizers dedicated commercialisation and development capabilities in anti-infectives.

AstraZeneca Pharma Indias net profit rose 288.6% to Rs 10.57 crore on 15% rise in net sales to Rs 138.09 crore in Q1 June 2016 over Q1 June 2015.

AstraZeneca Pharma India is present in seven crucial areas of healthcare-cardiovascular, diabetes, oncology, respiratory & inflammation, infection, local anesthesia and maternal healthcare. AstraZeneca Pharmaceuticals AB holds 75% stake in AstraZeneca Pharma India (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Engineers India extends gains after declaring strong Q1 results
Aug 25,2016

Meanwhile, the S&P BSE Sensex was up 65.58 points or 0.24% at 28,127.43

On BSE, so far 7.64 lakh shares were traded in the counter as against average daily volume of 1.23 lakhs shares in the past one quarter. The stock hit a high of Rs 266.50 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 252.10 so far during the day. The stock had hit a 52-week low of Rs 143.25 on 17 February 2016. The stock had outperformed the market over the past 30 days till 24 August 2016, rising 12.1% compared with Sensexs 0.3% rise. The scrip had also outperformed the market in past one quarter, gaining 37.72% as against Sensexs 6.42% rise.

The mid-cap company has equity capital of Rs 168.47 crore. Face value per share is Rs 5.

Engineers Indias net profit rose 50.07% to Rs 80.30 crore on 11.74% drop in total income to Rs 396.40 crore in Q1 June 2016 over Q1 June 2015. The stock rose 8.33% to settle at Rs 251 yesterday, 24 August 2016. The result was announced after market hours on 23 August 2016.

State-run Engineers India provides engineering consultancy and EPC services, mainly to the oil and gas and petrochemical industries. The company has also diversified into sectors like infrastructure, water and waste management, solar and nuclear power and fertilizers to leverage its strong technical competencies and track record. The government of India holds 59.37% in Engineers India (as per shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Jubilant Life Sciences scales record high
Aug 25,2016

The announcement was made before market hours today, 25 August 2016.

Meanwhile, the BSE Sensex was up 65.16 points, or 0.23%, to 28,123.95.

On BSE, so far 2.38 lakh shares were traded in the counter, compared with average daily volume of 1.63 lakh shares in the past one quarter. The stock hit a high of Rs 533.70, so far during the day, which is a record high for the stock. The stock hit a low of Rs 510.10 so far during the day. The stock hit a 52-week low of Rs 261 on 8 September 2015. The stock had outperformed the market over the past one month till 24 August 2016, surging 56.09% compared with 0.92% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 42.77% as against Sensexs 10.88% rise.

The mid-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences announced that it has received final approval for abbreviated new drug application (ANDA) for Felodipine Extended-Release Tablets USP, 2.5 mg, 5 mg, and 10 mg from United States Food & Drug Administration (USFDA). Felodipine Extended-Release Tablets are the generic version of Plendil Tablets of AstraZeneca, which is used for the treatment of hypertension.

As on 30 June 2016, Jubilant Life Sciences had a total of 770 filings for oral solids of which 578 have been approved in various regions globally. This includes 70 ANDAs filed in the US, of which 44 have been approved and 104 filings in Europe.

Jubilant Life Sciences consolidated net profit rose 22.5% to Rs 161.60 crore on 1.7% decline in net sales to Rs 1400.97 crore in Q1 June 2016 over Q1 June 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and drug discovery solutions. The companys strength lies in its unique offerings of pharmaceuticals and life sciences products and services across the value chain.

Powered by Capital Market - Live News

Ramco Systems spurts after overseas order win
Aug 25,2016

The announcement was made after trading hours yesterday, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 74.95 points, or 0.27%, to 28,134.89

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 2,293 shares in the past one quarter. The stock hit a high of Rs 563.40 and a low of Rs 520 so far during the day. The stock hit a 52-week high of Rs 900 on 9 November 2015. The stock hit a 52-week low of Rs 494 on 22 August 2016. The stock had underperformed the market over the past 30 days till 24 August 2016, falling 19.64% compared with Sensexs 0.3% rise. The scrip had also underperformed the market in past one quarter, sliding 27.67% as against Sensexs 6.42% rise.

The small-cap company has an equity capital of Rs 30.08 crore. Face value per share is Rs 10.

Ramco Systems said that the companys subsidiary, Ramco Systems Pte., Singapore, has secured an order from one of the top 5 most valuable global brands for Ramco HCM & Payroll in Asia-Pacific region (APAC).

Ramco Systems consolidated net profit dropped 91.35% to Rs 0.90 crore on 11.35% fall in total income to Rs 110.52 crore in Q1 June 2016 over Q4 March 2016.

Ramco Systems is a software products and services provider incorporated in India. Ramco Systems is a provider of enterprise resource planning, human capital management and aviation maintenance & engineering (M&E) & maintenance repair & overhaul (MRO) software.

Powered by Capital Market - Live News

Construction stocks gain after CCEA approves national highways improvement project
Aug 25,2016

The announcement was made after market hours yesterday, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 62.91 points or 0.22% at 28,122.85.

Hindustan Construction Company (up 5.79%), J. Kumar Infraprojects (up 5%), Lanco Infratech (up 2.52%), IVRCL (up 2.94%), IL&FS Transportation Networks (up 2.57%), L&T (up 0.41%), Valecha Engineering (up 1.16%), Patel Engineering (up 1.65%), NCC (up 0.06%) and Unity Infraprojects (up 1.06%) gained. IRB Infrastructure Developers fell 0.59%.

The Cabinet Committee on Economic Affairs, chaired by the Prime Minister Narendra Modi, approved development of 1,120 kilometers of National Highways in Karnataka, Odisha, Bihar, Rajasthan and West Bengal.

The work for development to two lane standards are under phase-I of the National Highways Interconnectivity Improvement Project (NHIIP) with World Bank assistance. The revised estimated cost of the project is Rs 6461 crore including cost of land acquisition, resettlement and rehabilitation and other pre-construction activities. The projects are already taken up for implementation and 429 kilometers has been completed. The civil works are expected to be completed by July 2019 and maintenance works are expected to be completed by July 2024.

The project will ensure safe, fast and all weather movement of traffic on the proposed National Highways mostly located in backward regions thereby improving socio economic development.

The proposal was initially approved for Rs 5193 crore. The cost has increased due to higher bid prices, and increase in cost of land acquisition, resettlement and rehabilitation and other pre-construction activities.

Powered by Capital Market - Live News

Man Infra gains after strong Q1 result
Aug 25,2016

The result was announced after market hours yesterday, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 75.49 points or 0.27% at 28,135.43

On BSE, so far 7.04 lakh shares were traded in the counter as against average daily volume of 3.50 lakh shares in the past one quarter. The stock hit a high of Rs 52.80 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 51.40 so far during the day. The stock had hit a 52-week low of Rs 28.85 on 12 February 2016. The stock had outperformed the market over the past 30 days till 24 August 2016, advancing 18.4% compared with Sensexs 0.3% rise. The scrip had also outperformed the market in past one quarter, surging 43.48% as against Sensexs 6.42% rise.

The small-cap company has equity capital of Rs 49.50 crore. Face value per share is Rs 2.

Man Infraconstruction is a construction company engaged in providing construction services for port infrastructure, residential, industrial, commercial and road infrastructure projects.

Powered by Capital Market - Live News

Rail stocks gain after CCEA approves nine rail network expansion projects
Aug 25,2016

The announcement was made by Ministry of Railways after market hours yesterday, 24 August 2016.

Meanwhile, the BSE Sensex was up 74.09 points, or 0.26%, to 28,136.58.

Hind Rectifiers (up 4.09%), NELCO (up 0.06%), Kalindee Rail Nirman (up 3.23%), Titagarh Wagons (up 5.64%), Stone India (up 4.2%), Kernex Microsystems (up 3.29%), BEML (up 0.39%), Texmaco Rail & Engineering (up 3.29%), and Zicom Electronic Security Systems (up 0.24%) gained.

The Cabinet Committee on Economic Affairs, chaired by the Prime Minister Narendra Modi in a major push to give a boost to the infrastructure sector in the country, approved nine projects worth Rs 24374.86 crore in nine states for expansion of railway network and connectivity across the country.

The nine projects include construction of second railway line between New Bongaigaon and Kamakhya in Assam; construction of third line between Kharagpur (Nimpura) and Adityapur in Jharkhand; construction of third line between Rajnandgaon-Nagpur (Kalumna) in Rajnandgaon district of Chhattisgarh and Gondia, Bhandara and Nagpur districts in Maharashtra; construction of third line between Mathura and Jhansi in Uttar Pradesh and construction of third line between Jhansi and Bina in Madhya Pradesh; construction of third line between Itarsi and Nagpur in Madhya Pradesh and Maharashtra; construction of third line between Ballarshah and Kazipet in Telangana and Maharashtra; construction of third line between Vijaywada and Gudur in Andhra Pradesh; and construction of fourth line between Jharsuguda and Bilaspur in Odisha and Chhattisgarh.

Besides facilitating the travel by easing the traffic bottlenecks, the approved lines would help the upcoming industries in the region and additional transport capacity to meet their requirements. The goods trains supplying foodgrains from one region to another, various industries, mines, coal fields and power plants will have additional transport capacity through these lines resulting in more revenues to Indian Railways, the statement from Ministry of Railways added.

Powered by Capital Market - Live News

PNC Infratech reaches summit after posting stellar Q1 results
Aug 25,2016

The result was announced after market hours yesterday, 24 August 2016.

Meanwhile, the BSE Sensex was up 65.37 points, or 0.23%, to 28,125.31.

High volumes were witnessed on the counter. On BSE, so far 1.24 lakh shares were traded in the counter, compared with an average volume of 2,382 shares in the past one quarter. The stock hit a high of Rs 134.90 so far during the day, which is a record high for the stock. The stock hit a low of Rs 124.80 so far during the day. The stock hit a 52-week low of Rs 69.26 on 23 September 2015. The stock had outperformed the market over the past one month till 24 August 2016, gaining 7% compared with 0.92% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 5.34% as against Sensexs 10.88% rise.

The mid-cap company has an equity capital of Rs 51.31 crore. Face value per share is Rs 10.

PNC Infratech said that the decline in total income from operations is attributed to application of Indian Accounting Standards (Ind-AS) for the first time. Based on Indian GAAP, however, consolidated revenue was higher by 26.9%, it added. Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) rose 25.4% to Rs 165.8 crore in Q1 June 2016 over Q1 June 2015. The EBITDA margin improved from 19.5% in Q1 June 2015 to 26.1% in Q1 June 2016. Net profit margin also improved from 3.2% in Q1 June 2015 to 8.5% in Q1 June 2016.

PNC Infratech is an infrastructure construction, development and management company, with expertise in execution of major infrastructure projects, including highways, bridges, flyovers, airport runways, power transmission lines, development of industrial areas and other infrastructure activities.

Powered by Capital Market - Live News

Bosch rises after fixing record date for buyback of equity shares
Aug 25,2016

The announcement was made after market hours yesterday, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 69.14 points or 0.25% at 28,129.08

On BSE, so far 113 shares were traded in the counter as against average daily volume of 2,188 shares in the past one quarter. The stock hit a high of Rs 23,786.65 and a low of Rs 23,600 so far during the day. The stock had hit a 52-week high of Rs 25,649.95 on 10 August 2016. The stock had hit a 52-week low of Rs 15,752.65 on 12 February 2016.

The large-cap company has equity capital of Rs 31.40 crore. Face value per share is Rs 10.

On 1 July 2016, board of directors of Bosch had approved buyback of 8.78 lakh fully paid up equity shares, or 2.79% equity, at Rs 23,000 per share through the tender offer route. The buyback offer aggregates to Rs 2019.76 crore. Boschs German parent Robert Bosch GmbH has decided to participate in the buyback offer. The foreign parent currently holds 71.18% stake (as per the shareholding pattern as on 30 June 2016).

Boschs net profit rose 0.8% to Rs 378.72 crore on 10.6% growth in total income to Rs 2702.26 crore in Q1 June 2016 over Q1 June 2015.

In India, Bosch is a leading supplier of technology and services in the areas of mobility solutions, industrial technology, consumer goods, and energy and building technology. Bosch is the flagship company of the Bosch Group in India

Powered by Capital Market - Live News

IDBI Bank gains on fund raising plan
Aug 25,2016

The announcement was made after market hours yesterday, 24 August 2016.

Meanwhile, the BSE Sensex was up 50.56 points, or 0.18%, to 28,110.50

On BSE, so far 1.58 lakh shares were traded in the counter compared with average daily volume of 6.44 lakh shares in the past one quarter. The stock hit a high of Rs 74.45 and a low of Rs 73 so far during the day. The stock hit a 52-week high of Rs 95.70 on 3 December 2015. The stock hit a 52-week low of Rs 47.40 on 12 February 2016.

The large-cap state-run bank has equity capital of Rs 2058.82 crore. Face value per share is Rs 10.

IDBI Banks net profit rose 78.35% to Rs 241.10 crore on 4% growth in total income to Rs 8,219.43 crore in Q1 June 2016 over Q1 June 2015.

The Government of India currently holds 73.98% stake in IDBI Bank (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Cyient gains as board to consider special dividend
Aug 24,2016

The announcement was made during market hours today, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 62.54 points or 0.22% at 28,052.75

On BSE, so far 20,000 shares were traded in the counter as against average daily volume of 4,357 shares in the past one quarter. The stock hit a high of Rs 538.90 and a low of Rs 510 so far during the day. The stock had hit a record high of Rs 641 on 15 October 2015. The stock had hit a 52-week low of Rs 370.50 on 12 February 2016. The stock had outperformed the market over the past 30 days till 23 August 2016, rising 5.65% compared with Sensexs 0.37% fall. The scrip, however, outperformed the market in past one quarter, outperforming 10.16% as against Sensexs 8.15% rise.

The mid-cap company has equity capital of Rs 56.27 crore. Face value per share is Rs 5.

Cyients consolidated net profit rose 11.97% to Rs 73.97 crore on 0.06% fall in total income to Rs 841.20 crore in Q1 June 2016 over Q4 March 2015.

Cyient provides engineering solutions, process, network and content engineering to major organizations worldwide.

Powered by Capital Market - Live News

Nava Bharat Ventures drops on dismal Q1 outcome
Aug 24,2016

The result was announced during market hours today, 24 August 2016.

Meanwhile, the BSE Sensex was up 63.06 points, or 0.23%, to 28,053.27.

More than normal volumes were witnessed on the counter. On BSE, so far 2.68 lakh shares were traded in the counter, compared with an average volume of 94,696 shares in the past one quarter. The stock hit a high of Rs 256.90 and a low of Rs 230.30 so far during the day.

Nava Bharat Ventures operates in the business verticals of power generation, mining, ferro alloys and agri-business with multi-national operations spread over India, South East Asia and Africa.

Powered by Capital Market - Live News

MOIL gains after executing mining lease in Madhya Pradesh
Aug 24,2016

The announcement was made after market hours yesterday, 23 August 2016.

Meanwhile, the S&P BSE Sensex was up 92.54 points or 0.33% at 28,082.75.

High volumes were witnessed on the counter. On BSE, so far 49,222 shares were traded in the counter as against average daily volume of 16,838 shares in the past one quarter. The stock hit a high of Rs 269.90 so far during the day, which is also a 52-week high for the stock. The stock hit a low of Rs 253.50 so far during the day. The stock had hit a record low of Rs 180.10 on 12 February 2016. The stock had outperformed the market over the past one month till 23 August 2016, gaining 4.75% compared with 0.67% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 9.85% as against Sensexs 10.94% rise.

The mid-cap company has equity capital of Rs 168 crore. Face value per share is Rs 10.

MOIL announced that it has executed mining lease over 76.409 hectares of land granted by Government of Madhya Pradesh in the village Bharweli-Awalajhari, Tehsil & District Balaghat of Madhya Pradesh. MOIL had announced on 25 July 2016 about receiving approval from the Government of Madhya Pradesh for mining lease of over 76.409 hectare land in Bharveli-Awalajhari village of MP.

MOILs net profit declined 79.1% to Rs 21.38 crore on 29.9% growth in net sales to Rs 209.62 crore in Q4 March 2016 over Q4 March 2015.

MOIL produces and sells different grades of manganese ore. Government of India holds 71.57% stake in MOIL (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Tata Power Company gains as generation capacity rises in Q1
Aug 24,2016

The announcement was made during market hours today, 24 August 2016.

Meanwhile, the S&P BSE Sensex was up 84.32 points, or 0.3%, to 28,074.53

On BSE, so far 6.96 lakh shares were traded in the counter, compared with average daily volume of 4.92 lakh shares in the past one quarter. The stock hit a high of Rs 76.45 and a low of Rs 74 so far during the day. The stock had hit 52-week high of Rs 79.20 on 22 August 2016. The stock had hit 52-week low of Rs 55 on 12 February 2016. The stock had outperformed the market over the past 30 days till 23 August 2016, rising 3.89% compared with Sensexs 0.37% fall. The scrip, however, underperformed the market in past one quarter, underperforming 2.26% as against Sensexs 8.15% rise.

The large-cap company has equity capital of Rs 270.46 crore. Face value per share is Re 1.

Tata Power Companys standalone generation stood at 3,163 million units (MUs) in Q1 June 2016. Total consolidated generation stood at 11,122 MUs in Q1 June 2016. The company has a significant presence in the clean energy space with a gross installed capacity of 1,996 MW.

Shares of Tata Power Company dropped 3.24% to Rs 74.75 after the company announced weak Q1 result during trading hours yesterday, 23 August 2016. Tata Power Companys consolidated net profit fell 76.09% to Rs 72.49 crore on 7.14% decline in total income to Rs 6790.58 crore in Q1 June 2016 over Q1 June 2015.

Tata Power Company is Indias largest integrated power company with a growing international presence. The company has presence in all the segments of the power sector viz. fuel security and logistics, generation (thermal, hydro, solar and wind), transmission, distribution and trading.

Powered by Capital Market - Live News

Strides Shasun gains amid high volumes after receiving USFDA approval for drug
Aug 24,2016

The announcement was made during market hours today, 24 August 2016.

Meanwhile, the S&P BSE Sensex was down 18.75 points or 0.07% at 27,971.46.

High volumes were witnessed on the counter. On BSE, so far 5.12 lakh shares were traded in the counter as against average daily volume of 39,803 shares in the past one quarter. The stock hit a high of Rs 981 and a low of Rs 957 so far during the day. The stock had hit record high of Rs 1,412.45 on 23 November 2015. The stock had hit a 52-week low of Rs 848 on 29 February 2016. The stock had underperformed the market over the past one month till 23 August 2016, sliding 18.05% compared with 0.67% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 9.37% as against Sensexs 10.94% rise.

The large-cap company has an equity capital of Rs 89.37 crore. Face value per share is Rs 10.

Ranitidine Tablets USP, 150 mg and 300 mg is the first integrated product approval where the active pharmaceutical ingredients (API) and formulations will be manufactured at erstwhile Shashun Pharmaceuticals Cuddalore and Pondicherry facilities respectively. It may be recalled that Strides Arcolab had announced acquisition of Shasun Pharma on 29 September 2014 and the merged companys name was later changed to Strides Shasun.

According to IMS June 2016 data, annual sales for Ranitidine Tables USP, 150 mg and 300 mg is around $125 million in US market. The product will be launched and marketed immediately by Strides Pharma Inc. in the US market.

Strides Shasuns consolidated net profit rose 145.2% to Rs 26.04 crore on 44.6% rise in net sales to Rs 844.62 crore in Q1 June 2016 over Q1 June 2015.

Strides Shasun is a vertically integrated global pharmaceutical company headquartered in Bangalore. The company has four business verticals, viz., regulated markets, emerging markets, institutional business and pharmaceutical services & active ingredients.

Powered by Capital Market - Live News